On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Marianne Clancy, Executive Director at Cure HHT, about the foundation and their goal of reducing the number of undiagnosed cases of HHT.
"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...
"It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they...
Can data sharing make the world a better place? Listen in to the latest episode of Few & Far Between. Biorasi CEO, Chris O'Brien,...